Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Wien Klin Wochenschr ; 134(11-12): 463-470, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35238988

RESUMO

OBJECTIVE: The aim of this study was to investigate the distribution of HLA-DRB1 alleles in patients with rheumatoid arthritis (RA) in the Sinj Region (SR) and the rest of the Split-Dalmatia County (SDC) in Croatia and to determine their relationship with disease severity. METHODS: A total of 74 RA patients and 80 healthy controls from the SR, and 74 RA patients and 80 healthy controls from the rest of the SDC were genotyped using sequence-specific oligonucleotide primed PCR. High-resolution typing of HLA-DRB1*04 alleles was performed using the single specific primed polymerase chain reaction (PCR-SSP) method. Serum anti-CCP, rheumatoid factor, C­reactive protein, and erythrocyte sedimentation rate were measured in all RA patients, whereas disease activity was assessed by DAS-28 and functional status by the Health Assessment Questionnaire Disability Index. RESULTS: The HLA-DRB1*04 allele was more frequent in patients with RA from the SR than that in patients from the rest of the SDC (18.2% vs. 9.5%; P = 0.014), whereas the HLA-DRB1*15 allele was more frequent in patients with RA from the rest of the SDC than in patients from the SR (16.2% vs. 7.4%; P = 0.010). Shared epitope (SE) positive patients from the SR had significantly higher serum anti-CCP and RF antibody levels (P = 0.014 and P = 0.004, respectively), higher disease activity (P = 0.043), and worse functional status (P < 0.001), than SE-positive patients from the rest of the SDC. CONCLUSION: The observed higher incidence of more severe forms of RA in the SR in comparison to the rest of the SDC might be associated with the higher incidence of HLA-DRB1*04 allele in the SR.


Assuntos
Artrite Reumatoide , Cadeias HLA-DRB1 , Alelos , Anticorpos Antiproteína Citrulinada , Artrite Reumatoide/epidemiologia , Artrite Reumatoide/genética , Autoanticorpos , Croácia/epidemiologia , Epitopos , Predisposição Genética para Doença , Genótipo , Cadeias HLA-DRB1/genética , Humanos , Peptídeos Cíclicos/genética , Fator Reumatoide
2.
Mod Rheumatol ; 26(2): 278-80, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-24289195

RESUMO

Stiff Person Syndrome (SPS) is a rare autoimmune neurological disorder characterized by progressive stiffness and rigidity of truncal muscles accompanied with co-contraction of agonist-antagonist muscles. Our 51-year-old female patient was presented for the first time to physiatrists in 2006 and diagnosed with axial-spondyloarthropathy (SpA) HLA-B27 positive. SPS was diagnosed 7 years after initial symptoms. SPS should be taken into consideration in HLA-B27 positive patients if stiffness of paravertebral and abdominal muscles progresses during SpA therapy.


Assuntos
Antígeno HLA-B27/imunologia , Músculo Esquelético/imunologia , Espondiloartropatias/complicações , Rigidez Muscular Espasmódica/complicações , Feminino , Humanos , Pessoa de Meia-Idade , Espondiloartropatias/imunologia , Rigidez Muscular Espasmódica/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA